NCT04401202View on ClinicalTrials.gov

Nigella Sativa in COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

May 21, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
COVID-19SARS-CoV-2
Interventions
DIETARY_SUPPLEMENT

Nigella sativa oil

Nigella sativa oil 500mg softgel capsules in oral twice daily dose for 10 days

Trial Locations (1)

21589

King Abdulaziz University Hospital, Jeddah

All Listed Sponsors
lead

King Abdulaziz University

OTHER

NCT04401202 - Nigella Sativa in COVID-19 | Biotech Hunter | Biotech Hunter